Records containing: Psoriasis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-01-29Evaluation of the Effect of Mirikizumab on the Pharmacokinetics of Cytochrome P450 Substrates in Patients With Moderate-to-Severe Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2024-01-26The APPLE Study; a Cross-sectional Study Exploring Diet, Life-style Patterns and Psoriasis Severity
-
CLINICAL_TRIALS study record update · 2024-01-25A Phase II Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Trial to Evaluate the Efficacy and Safety of IBI112 in Different Dose Regimens for the Treatment of Subjects With Moderate-to-severe Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2024-01-24A Randomized, Double-blind, Placebo-controlled Single and Multiple Dose Phase I Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Topical Ointment YR001 in Adult Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2024-01-19The Impact of Pollutants on Patients With Psoriasis or Atopic Dermatitis by Investigating the Activation of the Aromatic Hydrocarbon Receptor.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-01-18French Registry of Patients Initiating Systemic Treatment for Cutaneous Psoriasis
-
CLINICAL_TRIALS study record update · 2024-01-16A Phase Ⅲ Multicenter, Randomized, Double-blind, Placebo-controlled To Assess Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2024-01-12Immunoclassification of Psoriasis: a Strategy for Precision Medicine
-
CLINICAL_TRIALS study record update · 2024-01-12A Prospective Study With Induction Dosing Period Followed by a Maintenance Dosing Period to Evaluate the Efficacy and Safety of Etanercept （Yi Sai Pu) in Chinese Patients With Moderate-to-Severe Psoriasis
-
CLINICAL_TRIALS study record update · 2024-01-11A Multicenter, Randomized, Double-blinded Study Evaluating the Pharmacokinetics, Efficacy and Safety of Multiple Switches Between Ustekinumab and ABP 654 Compared With Continued Use of Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2024-01-09Efficacy and Safety Comparison of Brodalumab Versus Guselkumab in Adult Subjects With Moderate-to-severe Plaque Psoriasis and Inadequate Response to Ustekinumab
-
CLINICAL_TRIALS study record update · 2024-01-05Observational Study on GUselkumab: Effectiveness and Impact on quaLity of LIfe in naïVE or Bio Experienced Patients With Regional (Facial and Genital) Psoriasis (GULLIVER Study)
-
CLINICAL_TRIALS study record update · 2024-01-05A Real World Evidence Study in Chinese Psoriasis Patients
-
CLINICAL_TRIALS study record update · 2023-12-27Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis
-
CLINICAL_TRIALS study record update · 2023-12-19A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of QY101 Ointment in Patients With Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2023-12-18Treatment Patterns, Clinical Outcomes and Healthcare Resource Utilization Among Adult Patients With Moderate-To-Severe Plaque Psoriasis in Real-World Settings in China
-
CLINICAL_TRIALS study record update · 2023-12-15An Open Label, 4-Week, Phase 2, Maximal Usage Pharmacokinetics and Safety Study of ARQ-151 Cream 0.3% Administered QD in Pediatric Subjects (Ages 6 to 11 Years Old) With Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2023-12-15Incidence of Psoriatic Arthritis Among Psoriasis Patients Newly Initiated With Secukinumab in a US Claims Database and a UK Registry
-
CLINICAL_TRIALS study record update · 2023-12-13ClinicalTrials.gov study NCT03840928
-
CLINICAL_TRIALS study record update · 2023-12-13Oral Psoriasis Treatment Adherence and Intervention Study
-
CLINICAL_TRIALS study record update · 2023-12-07A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF APREMILAST (CC-10004) IN PEDIATRIC SUBJECTS FROM 6 THROUGH 17 YEARS WITH MODERATE TO SEVERE PLAQUE PSORIASIS
-
CLINICAL_TRIALS study record update · 2023-12-06A Multi-Center, Randomized, Double Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of HS-10374 in Adult Subjects With Moderate To Severe Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2023-11-29A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of Cedirogant (ABBV-157) in Adult Subjects With Moderate to Severe Psoriasis
-
CLINICAL_TRIALS study record update · 2023-11-22Interrelationships Among Inflammation, Physical Symptoms, Mental Symptoms and Quality of Life in Subjects With Chronic Inflammatory Physical Diseases.
-
CLINICAL_TRIALS study record update · 2023-11-15Validation of a Dermatology-Specific Treatment Satisfaction Instrument